New drug AMG 305 tested in patients with advanced cancers
NCT ID NCT05800964
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 26 times
Summary
This early-phase study tested a new drug, AMG 305, in 37 adults with advanced solid tumors who had no other treatment options. The main goals were to check the drug's safety and find the best dose for future studies. Researchers monitored side effects and how the drug moved through the body.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Asan Medical Center
Seoul, 05505, South Korea
-
Beatson West of Scotland Cancer Centre
Glasgow, G12 0YN, United Kingdom
-
Chris OBrien Lifehouse
Camperdown, New South Wales, 2050, Australia
-
Christie Hospital
Manchester, M20 4BX, United Kingdom
-
City of Hope National Medical Center
Duarte, California, 91010, United States
-
Freeman Hospital
Newcastle, NE7 7DN, United Kingdom
-
Gustave Roussy
Villejuif, 94805, France
-
Hackensack University Medical Center
Hackensack, New Jersey, 07601, United States
-
Hospital Clinic i Provincial de Barcelona
Barcelona, Catalonia, 08036, Spain
-
Hospital Universitari Vall d Hebron
Barcelona, Catalonia, 08035, Spain
-
Hospital Universitario 12 de Octubre
Madrid, 28041, Spain
-
Hospital Universitario Madrid Sanchinarro
Madrid, 28050, Spain
-
Institut Universitaire du Cancer Toulouse Oncopole
Toulouse, 31059, France
-
National Cancer Center Hospital East
Kashiwa-shi, Chiba, 277-8577, Japan
-
New York University Cancer Institute
New York, New York, 10016, United States
-
Next Oncology
San Antonio, Texas, 78229, United States
-
Peter MacCallum Cancer Centre
Melbourne, Victoria, 3000, Australia
-
Princess Margaret Cancer Centre
Toronto, Ontario, M5G 2C1, Canada
-
Royal Marsden Hospital
Sutton, SM2 5PT, United Kingdom
-
Sarah Cannon Research Institute
Nashville, Tennessee, 37203, United States
-
Sarah Cannon Research Institute UK
London, W1G 6AD, United Kingdom
-
Seoul National University Hospital
Seoul, 03080, South Korea
-
Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
-
Universitaetsklinikum Dresden
Dresden, 01307, Germany
-
Universitaetsklinikum Essen
Essen, 45147, Germany
-
Universitaetsklinikum Wuerzburg
Würzburg, 97078, Germany
-
University College London Hospital
London, W1T 7HA, United Kingdom
Conditions
Explore the condition pages connected to this study.